Study Reveals Public Opinion on Polygenic Embryo Screening for IVF
By Stephanie Dutchen,
Harvard Medical School
| 05. 14. 2024
At a glance:
Survey reveals nearly three-quarters of U.S. adults support using emerging technology to screen embryos during IVF for likelihood of developing certain health conditions or traits that arise from more than one gene.
Only about one-third of respondents approved of using the technology to predict traits unrelated to disease.
Nearly all expressed concerns about potential negative outcomes for individuals or society.
Findings underscore need for public education about benefits, limitations, ethical hazards of polygenic risk scores for embryos.
Three out of four adults in the U.S. support the use of emerging technologies that estimate a future child’s likelihood of developing certain health conditions influenced by multiple genes — such as diabetes, heart disease, and depression — before an embryo is implanted during in vitro fertilization (IVF), according to a new public opinion survey led by researchers at Harvard Medical School.
Results of the survey, published May 14 in JAMA Network Open, underscore the need for public education and conversation about the potential positive and negative implications of these ethically fraught technologies, the researchers said.
Although the approach...
Related Articles
Reproductive rights have been a flashpoint in national politics for decades, with the stakes surging after the Supreme Court shredded the right to an abortion. In the current presidential campaign, the battle over abortion has swelled and morphed to encompass in vitro fertilization (IVF), which has now moved rapidly from widely accepted to partisan hot button.
This dramatic shift was highlighted by the February decision of the Alabama Supreme Court that granted personhood rights to frozen IVF embryos, signaling that...
By Annalee Armstrong, BioSpace | 09.11.2024
Complex gene therapies are starting to hit the market but all have faced the same reality: a tepid reception from the healthcare system and a cloudy path to profitability.
It can take about a year for a patient to go...
By Julia Brown, The Conversation | 08.16.2024
With their primary goal to advance scientific knowledge, most scientists are not trained or incentivized to think through the societal implications of the technologies they are developing. Even in genomic medicine, which is geared toward benefiting future patients, time and...
By Smriti Mallapaty, Nature | 09.11.2024
Under his microscope, Jun Wu could see several tiny spheres, each less than 1 millimetre wide. They looked just like human embryos: a dark cluster of cells surrounded by a cavity, and then another ring of cells.
But Wu, a...